Antitumor effect of locally produced CD95 ligandKen‐ichiro Seino(Juntendo University), Nobuhiko Kayagaki(Juntendo University), Ko Okumura(Juntendo University), Hideo Yagita∥(Science and Technology Corporation (United States))Nature MedicineFebruary 1, 199710.1038/nm0297-165Cited by 312SaveCiteExport RISWatch citationsAbstractRelated PapersFas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeThomas S. Griffith, Thomas Brunner, Sharon M. Fletcher et al.|Science|1995|2kMonoclonal Antibody-Mediated Tumor Regression by Induction of ApoptosisB. C. Trauth, C Klas, Anke Peters et al.|Science|1989|1.7kA cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.Shin Yonehara, A Ishii, M Yonehara|The Journal of Experimental Medicine|1989|1.4kInterleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseEric R. Fearon, Drew M. Pardoll, Toshiuki Itaya et al.|Cell|1990|922Murine interleukin-4 displays potent anti-tumor activity in vivoRobert I. Tepper, Paul K. Pattengale, Philip Leder|Cell|1989|779